Enzyme engineering can yield changes in substrate specificity, but limited options exist when mutations are not causing the desired outcome. Selection of monobodies that bind near, but not at, a galactosidase active site now offers another avenue for altering product profiles.
- Shun-ichi Tanaka
- Tetsuya Takahashi
- Shohei Koide